Large-scale testing (Phase 3)Study completedNCT06470828What this trial is testingTAK-861 for the Treatment of Narcolepsy Type 1Who this might be right forNarcolepsy Type 1 Takeda 168
Early research (Phase 1)Study completedNCT05015673What this trial is testingThis is a Study to Determine the Effect of Multiple Doses of an Investigational Drug, Taken by Mouth, in People With Narcolepsy-cataplexy. Accepting Both Males and Females Ages of 18 Years to 55 Years. This Study Will be Conducted in the US and Will Require Approximately 13 Weeks Participation.Who this might be right forNarcolepsy Otsuka Pharmaceutical Development & Commercialization, Inc. 18
Large-scale testing (Phase 3)UnknownNCT05914194What this trial is testingA Eight-Week Study of NLS-2 (Mazindol Extended Release) in Participants With Narcolepsy Type 1Who this might be right forNarcolepsy Type 1Narcolepsy With Cataplexy NLS Pharmaceutics 48
Large-scale testing (Phase 3)Study completedNCT00061022What this trial is testingSafety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a StrokeWho this might be right forCerebral StrokeStroke, AcuteCerebrovascular Stroke+1 more AstraZeneca 3,200
Large-scale testing (Phase 3)Study completedNCT01638403What this trial is testingEffects of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy.Who this might be right forTreatment of Excessive Daytime Sleepiness in Narcolepsy Bioprojet 180
Large-scale testing (Phase 3)Study completedNCT00078377What this trial is testingSafety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With NarcolepsyWho this might be right forNarcolepsy Cephalon 196
Testing effectiveness (Phase 2)Study completedNCT03881852What this trial is testingClinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT)Who this might be right forNarcolepsyCataplexy NarcolepsyExcessive Sleepiness Axsome Therapeutics, Inc. 21
Large-scale testing (Phase 3)Study completedNCT02221869What this trial is testingStudy of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With CataplexyWho this might be right forNarcolepsy With Cataplexy Jazz Pharmaceuticals 106
Large-scale testing (Phase 3)Study completedNCT05113745What this trial is testingAssess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE)Who this might be right forNarcolepsyCataplexyExcessive Daytime Sleepiness Axsome Therapeutics, Inc. 68
Large-scale testing (Phase 3)Looking for participantsNCT07598708What this trial is testingInvestigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of HypersomnolenceWho this might be right forNarcolepsy Type 1Narcolepsy Type 2 Centessa Pharmaceuticals (UK) Limited 222
Testing effectiveness (Phase 2)Study completedNCT03772314What this trial is testingModafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic HypersomniaWho this might be right forIdiopathic HypersomniaNarcolepsy Without Cataplexy Emory University 44
Large-scale testing (Phase 3)Study completedNCT02720744What this trial is testingOnce-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in NarcolepsyWho this might be right forExcessive Daytime SleepinessCataplexyNarcolepsy Avadel 212
Testing effectiveness (Phase 2)Study completedNCT06358950What this trial is testingEvaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201)Who this might be right forNarcolepsy Type 1 Alkermes, Inc. 92
Large-scale testing (Phase 3)Active Not RecruitingNCT07363720What this trial is testingA Trial of TAK-861 for the Treatment of Narcolepsy With CataplexyWho this might be right forNarcolepsy Type 1 (NT1)Narcolepsy With Cataplexy Takeda 98
Not applicableStudy completedNCT02913651What this trial is testingCardiovascular Variability and Heart Rate Arousal Response in Idiopathic HypersomniaWho this might be right forNarcolepsyCataplexy Centre Hospitalier Universitaire de Saint Etienne 33
Testing effectiveness (Phase 2)Ended earlyNCT04820842What this trial is testingTAK-994 in Adults With NarcolepsyWho this might be right forNarcolepsy Type 1 (NT 1) Takeda 26
Testing effectiveness (Phase 2)Study completedNCT04072380What this trial is testingEvaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without CataplexyWho this might be right forNarcolepsy Suven Life Sciences Limited 190
Large-scale testing (Phase 3)Study completedNCT01067235What this trial is testingEfficacy and Safety Study of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With NarcolespyWho this might be right forNarcolepsyCataplexyExcessive Daytime Sleepiness Bioprojet 14
Large-scale testing (Phase 3)Looking for participantsNCT07540364What this trial is testingEvaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy (AWAKE)Who this might be right forNarcolepsy Suven Life Sciences Limited 240
Large-scale testing (Phase 3)Study completedNCT04451668What this trial is testingAn Open Label Study of FT218 in Subjects With NarcolepsyWho this might be right forNarcolepsyCataplexyExcessive Daytime Somnolence+3 more Avadel 184